| Hypertension |
1 |
1 |
| Myocardial Infarction (MI) |
0 |
0.83 |
| Heart Failure (HF) |
0 |
0.74 |
| Uncontrolled Hypertension |
0 |
0.58 |
| Antihypertensive Agents |
0 |
0.39 |
| Blood |
0 |
0.39 |
| Grant |
0 |
0.39 |
| Obesity |
0 |
0.33 |
| Heart |
0 |
0.29 |
| Plasma |
0 |
0.19 |
| Obstructive Sleep Apnea |
0 |
0.14 |
| Renal Disease |
0 |
0.14 |
| Chronic Kidney Disease |
0 |
0.12 |
| Renal Failure |
0 |
0.12 |
| Sleep Apnea |
0 |
0.11 |
| Sleep Disorders |
0 |
0.11 |
| Clinical Research |
0 |
0.1 |
| Controlled Hypertension |
0 |
0.1 |
| Hyperaldosteronism |
0 |
0.1 |
| Isolation |
0 |
0.1 |
| Kidney |
0 |
0.1 |
| Metabolism |
0 |
0.1 |
| Resistant Hypertension |
0 |
0.1 |
| Sleep |
0 |
0.1 |
| Metabolic Syndrome |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.07 |